HB 5230

  • Illinois House Bill
  • 101st Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Ins Cd-Proton Therapy Coverage

Abstract

Amends the Illinois Insurance Code. Provides that an individual or group policy of accident and health insurance that is amended, delivered, issued, or renewed on or after January 1, 2021 shall cover a medically necessary hypofractionated proton therapy protocol to deliver a biological effective dose by paying the same aggregate amount as would be paid for the delivery of the same biological effective dose with a standard radiation therapy protocol delivered with intensity modulated radiation therapy for the same indication if specified conditions are satisfied. Provides standards concerning the aggregate amount chargeable to or payable by an eligible patient for a covered course of hypofractionated proton therapy. Provides that proton therapy coverage may not impose an annual deductible, coinsurance, or other cost-sharing limitation that is greater than that required for radiation therapy and other similar benefits within the insurance policy or contract. Defines terms. Effective January 1, 2021.

Bill Sponsors (6)

Votes


No votes to display

Actions


Jun 23, 2020

House

Rule 19(b) / Re-referred to Rules Committee

Mar 12, 2020

House

To Health Insurance Subcommittee

Mar 04, 2020

House

Added Chief Co-Sponsor Rep. Norine K. Hammond

House

Added Chief Co-Sponsor Rep. Deb Conroy

House

Added Chief Co-Sponsor Rep. André Thapedi

House

Added Chief Co-Sponsor Rep. Jonathan Carroll

House

Added Co-Sponsor Rep. Mark Batinick

Feb 25, 2020

House

Assigned to Insurance Committee

Feb 18, 2020

House

Referred to Rules Committee

House

First Reading

Feb 14, 2020

House

Filed with the Clerk by Rep. Michael D. Unes

Bill Text

Bill Text Versions Format
Introduced HTML

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.